FR2289202B1 - - Google Patents

Info

Publication number
FR2289202B1
FR2289202B1 FR7532662A FR7532662A FR2289202B1 FR 2289202 B1 FR2289202 B1 FR 2289202B1 FR 7532662 A FR7532662 A FR 7532662A FR 7532662 A FR7532662 A FR 7532662A FR 2289202 B1 FR2289202 B1 FR 2289202B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7532662A
Other languages
French (fr)
Other versions
FR2289202A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp
Original Assignee
Pfizer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp filed Critical Pfizer Corp
Publication of FR2289202A1 publication Critical patent/FR2289202A1/fr
Application granted granted Critical
Publication of FR2289202B1 publication Critical patent/FR2289202B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/228—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to adjacent ring-carbon atoms of the cyclohexane rings
    • C07H15/23—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to adjacent ring-carbon atoms of the cyclohexane rings with only two saccharide radicals in the molecule, e.g. ambutyrosin, butyrosin, xylostatin, ribostamycin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7532662A 1974-10-26 1975-10-24 Nouveaux aminoglycosides de 2-deoxystreptamine, leur preparation et composition antibacterienne les contenant Granted FR2289202A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4641274A GB1464401A (en) 1974-10-26 1974-10-26 Aminoglycosides

Publications (2)

Publication Number Publication Date
FR2289202A1 FR2289202A1 (fr) 1976-05-28
FR2289202B1 true FR2289202B1 (da) 1978-11-10

Family

ID=10441164

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7532662A Granted FR2289202A1 (fr) 1974-10-26 1975-10-24 Nouveaux aminoglycosides de 2-deoxystreptamine, leur preparation et composition antibacterienne les contenant

Country Status (28)

Country Link
JP (1) JPS5519237B2 (da)
AR (1) AR205593A1 (da)
AT (1) AT340051B (da)
BE (1) BE834864A (da)
BG (1) BG24821A3 (da)
CA (1) CA1039275A (da)
CH (1) CH601339A5 (da)
CS (1) CS195712B2 (da)
DD (1) DD122522A5 (da)
DE (1) DE2547738C3 (da)
DK (1) DK147075C (da)
EG (1) EG11975A (da)
ES (1) ES442051A1 (da)
FI (1) FI752951A (da)
FR (1) FR2289202A1 (da)
GB (1) GB1464401A (da)
HU (1) HU172060B (da)
IE (1) IE42452B1 (da)
IL (1) IL48263A (da)
LU (1) LU73644A1 (da)
NL (1) NL162081C (da)
NZ (1) NZ179050A (da)
PH (1) PH12782A (da)
PL (1) PL99933B1 (da)
RO (1) RO72878A (da)
SE (1) SE7511945L (da)
SU (1) SU617017A3 (da)
ZA (1) ZA756326B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0000473B1 (en) * 1977-06-24 1981-03-11 Scherico Ltd. Process for preparing aminoglycoside derivatives, novel derivatives obtained and pharmaceutical compositions containing such derivatives
JPS5488241A (en) * 1977-12-21 1979-07-13 Kyowa Hakko Kogyo Co Ltd Novel fortimicin a derivative
JPS57118475U (da) * 1981-01-14 1982-07-22

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH606076A5 (da) * 1973-08-06 1978-10-13 Scherico Ltd

Also Published As

Publication number Publication date
AU8598175A (en) 1976-12-09
GB1464401A (en) 1977-02-16
PL99933B1 (pl) 1978-08-31
DK481175A (da) 1976-04-27
ZA756326B (en) 1976-09-29
RO72878A (ro) 1983-07-07
DE2547738A1 (de) 1976-05-06
FR2289202A1 (fr) 1976-05-28
IL48263A0 (en) 1975-12-31
CA1039275A (en) 1978-09-26
NL7512465A (nl) 1976-04-28
BG24821A3 (en) 1978-05-12
EG11975A (en) 1978-06-30
LU73644A1 (da) 1977-05-31
DD122522A5 (da) 1976-10-12
AT340051B (de) 1977-11-25
NL162081C (nl) 1980-04-15
CH601339A5 (da) 1978-07-14
DE2547738C3 (de) 1978-08-03
NL162081B (nl) 1979-11-15
BE834864A (fr) 1976-04-26
IE42452L (en) 1976-04-26
JPS5168543A (da) 1976-06-14
FI752951A (da) 1976-04-27
JPS5519237B2 (da) 1980-05-24
IE42452B1 (en) 1980-08-13
HU172060B (hu) 1978-05-28
PH12782A (en) 1979-08-17
ATA809575A (de) 1977-03-15
DK147075C (da) 1984-11-05
SE7511945L (sv) 1976-04-27
ES442051A1 (es) 1977-04-01
DK147075B (da) 1984-04-02
CS195712B2 (en) 1980-02-29
DE2547738B2 (de) 1977-12-01
SU617017A3 (ru) 1978-07-25
AR205593A1 (es) 1976-05-14
IL48263A (en) 1978-03-10
RO72878B (ro) 1983-06-30
NZ179050A (en) 1978-03-06

Similar Documents

Publication Publication Date Title
JPS50148752A (da)
BR7501650A (da)
DK582675A (da)
FR2289202B1 (da)
JPS50111371A (da)
JPS50149235A (da)
JPS5352589Y2 (da)
JPS50140861A (da)
JPS50112677A (da)
AU479230B2 (da)
JPS50123418U (da)
JPS50108697A (da)
AU7474774A (da)
JPS50136911U (da)
AU1893276A (da)
JPS50136302U (da)
BG20739A1 (da)
CH576246A5 (da)
BG20418A1 (da)
BG19776A1 (da)
BG20443A1 (da)
BG20901A1 (da)
CH576480A5 (da)
BG19728A1 (da)
AU481423A (da)

Legal Events

Date Code Title Description
ST Notification of lapse